Good info...appreciate it. See more positive reasons to continue holding this stock then moving my money elsewhere....we'll see how the year pans out!
Taking a second look through the Codexis Corp slides put out by Codexis last month Feb 2014, specifically the slide on Pg 11, is a reference to Glycom/Nestle. Doing a little research, it appears those two companies combined forces in 2006 specifically to develop a formula for babies that is an exact replication of human milk oligosaccharides. From what I'm reading they are attempting to go commercial scale with this in the near future and something they've been working on diligently since combining forces. The slides Codexis put out show they are complete with "phase two" of the project, with three phases being the total number required for development of any project prior to launch. This could be huge in itself! Might want to buy Nestle stock to boot! I've been trying to figure out who the 'food ingredient' company the CEO has alluded to they are working with but not allowed to mention for whatever reason by name, and am now 99% sure Nestle's it.
Too bad they didn't sell the Hungarian satellite office last quarter, would have offset the numbers favorably. If anything, should reflect positively on next quarters results. If they happen to close the loop on any of the current projects they are working with Merck, Pfizer, etc this quarter, am thinking this could quickly rebound to previous values. Unlike other stocks out there, the pps has remained pretty steady past few months so am thinking mostly long term investors here now.
Google CDXS Presentation. There is an interesting Corp Presentation from last month they released but not available on their website. Page 11 of the presentation shows what projects they are working on, with whom, and at what stage they are in in reference to "launch". Counting the current projects from that presentation, they have 21 currently in the final stages of development and nearing the "launch" phase. I had the link, but keeps deleting this post so removed it.
Not sure why that headline didn't post on this website, but thought it was worth passing along. Not sure....was looking at Merck's 4Q financial report for possible indication, but nothing there. Company is kind of quite lately.....am hoping they hit their numbers or do better based on the update given last quarter. Would like them to announce who in the food industry they are working with but doubt that will happen. It will be interesting to hear more on the multiple patents they recently acquired and what that means looking forward. Hopefully good news since we saw an influx of investors as a result....nothing was really mentioned in a statement as to the significance. Holding on this one as a sleeper......hopefully pays offs down the road!
Dyadic has withdrawn its notice of breach letter to Codexis dated July 30, 2013 relating to its C1 license agreement with Codexis. Furthermore, Dyadic and Codexis are continuing to discuss Codexis' use of Dyadic's technology and potential collaboration opportunities in the space.
Diversified vs. Not Diversified
Positive Cash Flow vs. Negative Cash Flow
Strong Management vs. Weak Management
Not Bankrupt vs. Soon to be Bankrupt
Not sure what these guys know....huge investment made by them last week.
Wonder what news could spark such a steep climb in price and at huge volumes? Haven't found any posting yet......possibly back in the biofuels business?
Sentiment: Strong Buy